Commercial Manufacturing

Your project is always a priority at Serán! Serán’s facilities provide flexible unit operations and adaptable suites to accommodate the unique needs of every program. Our ability to adjust to program volumes and flex with demands gives you peace of mind knowing milestones and timelines will always be met. Serán’s platform technologies, including our industry leading “right from the start” development paradigm results in smooth transition, validation, and tech transfer of your product from development to commercial. Our modular approach along with exceptional quality standards will get your drug product onto the market quickly.

Serán’s 50,000 ft2 greenfield commercial pharmaceutical manufacturing facility slated for operation Q2, 2027 will support advanced process and formulations to produce non-sterile solid dose commercial products.

Capabilities include:

  • Semi-continuous spray drying and secondary drying
  • Twin-screw extrusion and wet granulation
  • Mixing/blending and dry granulation using roller compaction
  • Single- and multi-layer tableting and encapsulation
  • Flexible tablet coating using interchangeable pan size
  • Integrated analytical lab enables rapid results and operational support
  • Bottle/Blister/Sachet packaging, labeling and serialization

Scalable Unit Operations

Custom manufacturing systems and systems from industry leading OEMs that are functionally equivalent to clinical equipment to maximize synergies during site transfer and scaleup activities

Quality and regulatory warehouse & supply chain

Harmonized quality systems and programs to facilitate an efficient, safe, compliant, cost-effective phase-in progression of projects from clinical through commercial manufacturing operations

Warehouse & supply chain

48,000 ft2 production and warehouse facility to support newly expanded clinical manufacturing and future commercial scale production. Completed May 2025.

Packaging, labeling and shipping

Capability to provide complete turnkey packaging services in bottles and blisters with different levels of serialization according to client aggregation requirements

COMMERCIAL
SPRAY DRYING

SD-720 to be installed supports 10-100+kg with solution spray rates of of ≥ 2 kg/min

Triton commercial facility flow rendering

Serán’s ~48,000 ft2 warehouse support facilities (Umpqua N. & S.) completed May, 2025 will enable advanced materials management, packaging, labeling, and other supporting functions.

Capabilities

  • Semi-continuous spray drying and secondary drying
  • Twin-screw extrusion and wet granulation
  • Advanced mixing/blending and dry granulation using roller compaction
  • Multi-layer tableting and broad encapsulation capabilities
  • Advanced batch, semi-continuous, and continuous tablet coating
  • Integrated automation, process control technologies and on-site analytical lab enables operational and quality control
  • Bottle/blister/sachet packaging, labeling and serialization
  • Supply chain for worldwide distribution
  • Close proximity to international airport and port of entry
  • End-to-end processing in one location

Technologies

  • Spray drying
  • Hot melt extrusion
  • Nano-milling
  • Fluid-bed
  • Controlled and modified release
  • Tableting
  • Capsule filling
  • Granulation
  • Encapsulation
  • Powder filling
  • Coatings
  • Packaging & labeling
  • Supply chain
Corporate headquarters

Empire Campus

~ 90,000 sf development and cGMP clinical manufacturing facilities

14 ISO 8 cGMP Suites
Development suites
FiH to Phase III

200 Employees

PhD Chemical Engineering
Bachelor Chemical Engineering
Bachelor in Biology or other sciences
Degreed other

Juniper Ridge Campus - Supply Chain Facilities

~48,000 sf warehouse and light manufacturing facilities

  • 2 fully functioning supply chain facilities
  • Inbound raw material storage
  • Primary Packaging
  • Labeling and Serialization
  • Finished material packaging
  • Finished material storage and shipping
  • 2,000 sf office and meeting space
  • Conveniently located on the same block as the new commercial facility and only 2 miles from the Empire Campus
  • Juniper Ridge Campus - Commercial Manufacturing

    Groundbreaking August, 2025 - Completion Spring 2027
    Scheduled to be operation in 2027, this facility will offer large-scale oral solid dose manufacturing.

    ~60,000 sf fully FDA approved commercial manufacturing facility

    • Spray drying
    • Hot melt extrusion
    • Dry granulation
    • Milling
    • Oral solid dosage forms:
      • Tablets
      • Capsules
      • Mini-tabs
      • Beads
      • Oral solutions
      • Powder in bottle
    • Enhanced and conventional dosage forms
    Serán announced a $200 m expansion for commercial oral solid manufacturing
    Corporate headquarters

    Corporate Headquarters

    Serán BioScience, LLC
    63047 Layton Avenue
    Bend, OR 97701
    (541) 797-2148

    FACILITIES AT A GLANCE

    90,000 ft2
    Development & Production on 2 Campuses
    30,000 ft2
    Clinical Manufacturing Capacity
    50,000 ft2
    Commercial manufacturing Facility (Future operation - Q2 - 2027)
    50,000 ft2
    Warehouse for advanced materials management, packaging, labeling, and other supporting functions
    Plan your visit today

    Empire Campus

    ~ 90,000 sf development and cGMP clinical manufacturing facilities

    14 ISO 8 cGMP Suites
    Development suites
    FiH to Phase III

    200 Employees

    PhD Chemical Engineering
    Bachelor Chemical Engineering
    Bachelor in Biology or other sciences
    Degreed other

    Juniper Ridge Campus - Supply Chain Facilities

    ~48,000 sf warehouse and light manufacturing facilities

  • 2 fully functioning supply chain facilities
  • Inbound raw material storage
  • Primary Packaging
  • Labeling and Serialization
  • Finished material packaging
  • Finished material storage and shipping
  • 2,000 sf office and meeting space
  • Conveniently located on the same block as the new commercial facility and only 2 miles from the Empire Campus
  • Juniper Ridge Campus - Commercial Manufacturing

    Groundbreaking August, 2025 - Completion Spring 2027
    Scheduled to be operation in 2027, this facility will offer large-scale oral solid dose manufacturing.

    ~60,000 sf fully FDA approved commercial manufacturing facility

    • Spray drying
    • Hot melt extrusion
    • Dry granulation
    • Milling
    • Oral solid dosage forms:
      • Tablets
      • Capsules
      • Mini-tabs
      • Beads
      • Oral solutions
      • Powder in bottle
    • Enhanced and conventional dosage forms
    Serán announced a $200 m expansion for commercial oral solid manufacturing